» Articles » PMID: 28318682

Predicting Neurofibromatosis Type 1 Risk among Children with Isolated Café-au-lait macules

Overview
Specialty Dermatology
Date 2017 Mar 21
PMID 28318682
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although isolated cafe-au-lait macules (CALMs) are a common skin finding, they are an early feature of neurofibromatosis type 1 (NF1).

Objective: We sought to develop an algorithm determining the risk of children with CALMs to have constitutional NF1.

Methods: We conducted a retrospective study of patients with isolated CALMs. Diagnosis of NF1 was based on detecting NF1 mutation in blood or fulfilling clinical criteria.

Results: In all, 170 of 419 (41%) and 21 of 86 (24%) children with isolated CALMs who underwent molecular testing and clinical follow-up, respectively, were given a diagnosis of NF1. Presence of fewer than 6 CALMs at presentation or atypical CALMs was associated with not having NF1 (P < .001). An algorithm based on age, CALMs number, and presence of atypical macules predicted NF1 in both cohorts. According to the algorithm, children older than 29 months with at least 1 atypical CALM or less than 6 CALMs have a 0.9% (95% confidence interval 0%-2.6%) risk for constitutional NF1 whereas children younger than 29 months with 6 or more CALMs have a high risk (80.4%, 95% confidence interval 74.6%-86.2%).

Limitations: The study was designed to detect constitutional NF1 and not NF1 in mosaic form.

Conclusions: A simple algorithm enables categorization of children with isolated CALMs as being at low or high risk for having NF1.

Citing Articles

Increased Phenotype Severity Associated with Splice-Site Variants in a Hungarian Pediatric Neurofibromatosis 1 Cohort: A Retrospective Study.

Veres K, Nagy B, Ember Z, Bene J, Hadzsiev K, Medvecz M Biomedicines. 2025; 13(1).

PMID: 39857730 PMC: 11762399. DOI: 10.3390/biomedicines13010146.


A Comprehensive Overview of NF1 Mutations in Iranian Patients.

Savad S, Modarressi M, Younesi S, Seifi-Alan M, Samadaian N, Masoomy M Neuromolecular Med. 2024; 26(1):28.

PMID: 38954284 DOI: 10.1007/s12017-024-08790-5.


Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.

Kehrer-Sawatzki H, Cooper D Hum Genet. 2021; 141(2):177-191.

PMID: 34928431 PMC: 8807470. DOI: 10.1007/s00439-021-02410-z.


Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.

Wang W, Wei C, Cui X, Li Y, Gu Y, Gu B Front Neurol. 2021; 12:704639.

PMID: 34566848 PMC: 8455870. DOI: 10.3389/fneur.2021.704639.


Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland.

Karwacki M, Wysocki M, Perek-Polnik M, Jatczak-Gaca A Arch Med Sci. 2021; 17(5):1221-1231.

PMID: 34522251 PMC: 8425254. DOI: 10.5114/aoms.2019.85143.